Phosphorylation of tyrosine 1248-ERBB2 measured by chemiluminescence-linked immunoassay is an independent predictor of poor prognosis in primary breast cancer patients-Reference-Cited by-同舟云学术

Phosphorylation of tyrosine 1248-ERBB2 measured by chemiluminescence-linked immunoassay is an independent predictor of poor prognosis in primary breast cancer patients

Published:2006-03 Issue:5 Volume:42 Page:636-645
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Cicenas Jonas,Urban Patrick,Küng Willy,Vuaroqueaux Vincent,Labuhn Martin,Wight Edward,Eppenberger Urs,Eppenberger-Castori Serenella

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor;Schechter;Science,1985

2. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185;Bargmann;Cell,1986

3. Untangling the ErbB signalling network;Yarden;Nat Rev Mol Cell Biol,2001

4. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor;Tzahar;Mol Cell Biol,1996

5. Cell signaling by receptor tyrosine kinases;Schlessinger;Cell,2000

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the therapeutic potential of Ponatinib and Imatinib against Aurora Kinase A in gastric cancer cells;2023-07-27

2. HER2 Expression in Peritoneal Dissemination of High-Grade Serous Ovarian Carcinoma: A Comparative Study of Immunohistochemical Reactivity Using Four HER2 Antibodies;Journal of Clinical Medicine;2022-11-25

3. Non-phosphorylated Tyr-1248 form of human epidermal growth factor receptor 2 (HER2) predicts resistance to trastuzumab therapy and poor disease-free survival of HER2-positive breast cancer patients;Croatian Medical Journal;2022-04

4. Laser Capture Proteomics: spatial tissue molecular profiling from the bench to personalized medicine;Expert Review of Proteomics;2021-10-03

5. Targeting kinases with thymoquinone: a molecular approach to cancer therapeutics;Drug Discovery Today;2020-12